Ebola - Underscoring the Global Disparities in Health Care Resources

At the start of the COVID-19 pandemic, high levels of distress, overwhelm with daily problems, and unmet psychosocial information needs decreased caregiver-reported health-related quality of life in children with rare diseases.

On this episode of Managed Care Cast, Ari D. Panzer, BS, lead author and researcher, then at Tufts Medical Center—now at Duke University—discusses the findings from his team’s investigation into coverage decisions by health plan insurers of the 66 drugs approved by the FDA in 2018.

High bleeding risk was seen among patients hospitalized with acute myocardial infarction (AMI) who had essential thrombocythemia (ET), particularly those treated with percutaneous coronary intervention.

On this episode of Managed Care Cast, we bring you an excerpt of an interview with an expert in Huntington disease, who discusses the reaction after 2 highly anticipated clinical trials ended this year.

A new review article shows how technologies like next-generation sequencing might help clinicians tailor care for myelodysplastic syndromes (MDS).

Data from the secondary analysis show that the improvements seen in health-related quality of life (HRQOL) translated into clinical improvements.